We are live on ! Find out more
MD icon

Pediatrix Medical

334 hedge funds and large institutions have $5.78B invested in Pediatrix Medical in 2014 Q2 according to their latest regulatory filings, with 44 funds opening new positions, 109 increasing their positions, 142 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 44 | Existing positions closed: 22

6% more funds holding

Funds holding: 314334 (+20)

0.13% less ownership

Funds ownership: 100.28%100.15% (-0.13%)

3% less call options, than puts

Call options by funds: $3.98M | Put options by funds: $4.09M

7% less capital invested

Capital invested by funds: $6.22B → $5.78B (-$435M)

17% less funds holding in top 10

Funds holding in top 10: 65 (-1)

23% less repeat investments, than reductions

Existing positions increased: 109 | Existing positions reduced: 142

Holders
334
Holders Change
+20
Holders Change %
+6.37%
% of All Funds
9.59%
Holding in Top 10
5
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-16.67%
% of All Funds
0.14%
New
44
Increased
109
Reduced
142
Closed
22
Calls
$3.98M
Puts
$4.09M
Net Calls
-$114K
Net Calls Change
-$4.37M
Name Holding Trade Value Shares
Change
Change in
Stake
OAM
151
Oxford Asset Management
United Kingdom
$2.92M +$406K +6,899 +16%
CNB
152
City National Bank
California
$2.9M +$605K +10,274 +26%
HW
153
Hancock Whitney
Mississippi
$2.87M +$339K +5,755 +13%
ProShare Advisors
154
ProShare Advisors
Maryland
$2.82M +$2.06M +35,006 +261%
SOMRS
155
State of Michigan Retirement System
Michigan
$2.72M -$47.1K -800 -2%
MSA
156
Mason Street Advisors
Wisconsin
$2.68M -$101K -1,714 -4%
LPL Financial
157
LPL Financial
California
$2.61M +$47.8K +813 +2%
SG Americas Securities
158
SG Americas Securities
New York
$2.56M +$1.98M +33,596 +319%
PRCM
159
Pine River Capital Management
Minnesota
$2.56M -$5.3M -90,150 -67%
WG
160
Winton Group
United Kingdom
$2.47M +$2.5M +42,453 New
Nisa Investment Advisors
161
Nisa Investment Advisors
Missouri
$2.43M -$58.8K -1,000 -2%
SFU
162
Stonehage Fleming (UK)
United Kingdom
$2.38M +$2.41M +40,900 New
RFC
163
Regions Financial Corp
Alabama
$2.35M +$77.1K +1,311 +3%
BG
164
BlackRock Group
United Kingdom
$2.35M -$1.91M -32,426 -45%
HighTower Advisors
165
HighTower Advisors
Illinois
$2.33M +$103K +1,750 +5%
IGIM
166
I.G. Investment Management
Manitoba, Canada
$2.29M +$651K +11,071 +39%
N
167
Nuveen
North Carolina
$2.26M -$5.44M -92,471 -70%
MIU
168
Man Investments (UK)
United Kingdom
$2.16M +$355K +6,036 +19%
TI
169
Turner Investments
Pennsylvania
$1.9M -$1.19M -20,140 -38%
BUB
170
BBVA USA Bancshares
Texas
$1.89M +$739K +12,552 +63%
CCMG
171
Clark Capital Management Group
Pennsylvania
$1.82M +$76K +1,291 +4%
Fifth Third Bancorp
172
Fifth Third Bancorp
Ohio
$1.81M -$57.8K -983 -3%
SCM
173
Sterling Capital Management
North Carolina
$1.8M -$95.8K -1,628 -5%
B
174
Baird
Wisconsin
$1.78M -$55.8K -949 -3%
SB
175
Suntrust Banks
Georgia
$1.77M -$495K -8,418 -22%

MD Hedge Fund Activity: Q2 2014 in Review

334 of the 3,481 institutional investors tracked by Wall St. Rank reported a position in Pediatrix Medical (MD) for Q2 2014, worth a combined $5.78B — down 7% from $6.22B a quarter earlier.

Buyers outnumbered sellers: 44 funds opened new MD positions and 22 closed out — a net gain of 22 holders — while 109 added to existing stakes and 142 trimmed.

The largest buyer was Wells Fargo, adding an estimated $70.6M. The largest seller was Fidelity Investments, cutting an estimated $183M.

  • 334 institutional investors held Pediatrix Medical (MD) as of Q2 2014, up from 314 in Q1 2014.
  • Funds reported $5.78B of Pediatrix Medical stock for Q2 2014, down 7% quarter-over-quarter.
  • 44 funds opened new Pediatrix Medical positions in Q2 2014 and 22 closed out, a net change of +22 holders.
  • The largest Pediatrix Medical buyer in Q2 2014 was Wells Fargo, an estimated $70.6M added.
  • The largest Pediatrix Medical seller in Q2 2014 was Fidelity Investments, an estimated $183M sold.

Based on aggregated 13F filings for Q2 2014.